Reality Check on Antiphospholipid Antibodies in COVID-19-Associated Coagulopathy.

Gkrouzman, Elena; Barbhaiya, Medha; Erkan, Doruk; Lockshin, Michael D

Gkrouzman, Elena; Barbhaiya, Medha; Erkan, Doruk; Lockshin, Michael D.

Gkrouzman E; Hospital for Special Surgery, Weill Cornell Medicine, New York, NY.
Barbhaiya M; Hospital for Special Surgery, Weill Cornell Medicine, New York, NY.
Erkan D; Hospital for Special Surgery, Weill Cornell Medicine, New York, NY.
Lockshin MD; Hospital for Special Surgery, Weill Cornell Medicine, New York, NY.

Arthritis Rheumatol ; 73(1): 173-174, 2021 01.

Article in English | MEDLINE | ID: covidwho-690525

Subject(s)

Antibodies, Antiphospholipid/immunology; Antiphospholipid Syndrome/diagnosis; COVID-19/immunology; Thrombophilia/immunology; Antibodies, Anticardiolipin/immunology; Antiphospholipid Syndrome/blood; Antiphospholipid Syndrome/immunology; COVID-19/blood; Humans; Immunoglobulin M/immunology; Lupus Coagulation Inhibitor/immunology; SARS-CoV-2; Thrombophilia/blood; Thrombosis/blood; Thrombosis/immunology; beta 2-Glycoprotein I/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiphospholipid Syndrome / Antibodies, Antiphospholipid / Thrombophilia / COVID-19 Type of study: Diagnostic study Limits: Humans Language: English Journal: Arthritis Rheumatol Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google